Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus
PRECISE
Feasibility of PRospective Surveillance and Early PhysiCal Therapy for TrIsmuS in Individuals With Head and Neck CancEr: A Single-Group Feasibility Trial (PRECISE)
1 other identifier
interventional
30
1 country
1
Brief Summary
Trismus, or restricted jaw movement, can occur in individuals with head and neck cancer (HNC) undergoing surgery or radiation therapy. There is a paucity of research examining interventions for trismus. We aim to assess the feasibility of prospective surveillance and early intervention to mitigate trismus in individuals undergoing HNC treatment. Method: The investigators will conduct a pilot single group feasibility study involving 30 individuals with HNC who will be undergoing radiation therapy. Participants will be identified at the HNC new patient clinic. Participants will be seen weekly during radiation therapy and will receive early intervention including manual therapy and a device-based jaw exercise regimen if presenting with 5% or greater reduction in jaw opening compared to pre-treatment. The investigators will assess recruitment and completion rates, intervention acceptability, and data collection procedures. Descriptive statistics will summarize feasibility metrics and participant demographics. Findings will inform the design of a larger multicentre trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable head-and-neck-cancer
Started Mar 2025
Shorter than P25 for not_applicable head-and-neck-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedFebruary 5, 2026
February 1, 2026
11 months
July 23, 2024
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility: completion rate
Number of participants completing the study.
2 years
Secondary Outcomes (8)
Feasibility: recruitment rate
2 years
Feasibility: adherence rate
6 weeks.
Maximal interincisal opening
3 months
Trismus symptom questionnaire
3 months
Quality of life related to Head and Neck Cancer
3 months
- +3 more secondary outcomes
Study Arms (1)
Prospective Surveillance for Trismus and Early Physical Therapy Intervention
EXPERIMENTALWeekly monitoring of mouth opening and jaw function. Early intervention if the participant presents with 5% or greater reduction in mouth opening compared to pre-treatment measures. Early intervention will comprise: physical therapy, home exercises and use of a jaw stretching device.
Interventions
Physical therapy including manual therapy, home exercises for the neck and jaw, and use of a jaw stretching device.
Eligibility Criteria
You may qualify if:
- Have a diagnosis of oral, oropharyngeal, or nasopharyngeal cancer
- Be scheduled to undergo cancer treatment that includes radiation therapy
- Be able to read and understand English
- Be an Alberta resident.
You may not qualify if:
- Previous surgery for the temporomandibular joint that is not related to the HNC diagnosis.
- Local cancer recurrence or metastatic disease.
- Unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Alberta Health servicescollaborator
Study Sites (1)
University of Alberta/ Cross Cancer Institute
Edmonton, Alberta, T6G 2G4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret McNeely, PhD
University of Alberta
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2024
First Posted
July 31, 2024
Study Start
March 1, 2025
Primary Completion
January 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available following publication of the primary paper.
- Access Criteria
- On request from research team
Data will be available on Borealis (University of Alberta)